Anticancer agent 269

• Target :

  Apoptosis|||Reactive Oxygen Species|||Caspase|||ROS

• Related Pathways :

  Immunology/Inflammation|||Proteases/Proteasome|||NF-?B|||Metabolism|||Apoptosis

• Bioactivity :

  Anticanceragent 269 (Compound 11c) is an orally active caspase-3 activator that exhibits significant anticancer activity by inducing apoptosis through the activation of caspase-3 and promoting ROS generation. It is a valuable compound for research within the cancer field.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C